Kura Spins Out $50 Million Diabetes Biotech to Pursue a Potentially Disease-Changing Treatment
Kura Oncology is taking technology originally developed around cancer biology into the enormous diabetes market, launching a new company called Caspian Therapeutics with $50 million in financing to investigate whether menin inhibitors can restore the body’s ability to produce insulin. The scientific idea behind Caspian could represent an important departure from many existing diabetes treatments. […]
Grail’s Galleri Cancer Test Faces Landmark FDA Review After Mixed Clinical Results
Grail’s ambitious effort to transform cancer screening is approaching a pivotal regulatory moment. The U.S. Food and Drug Administration has scheduled an advisory committee meeting for September 23, 2026, to evaluate the company’s Galleri multi-cancer early detection blood test. It will be the first FDA advisory panel convened to consider a premarket approval application for […]
